Jio Financial Services made headlines following its Q2 results, as the firm saw net profits rise by 3%. Amidst this, it was revealed that the company’s stocks were up by 41% in 2024 so far. The firm will continue this streak as Jio Financial seeks to collaborate with Allianz SE, a prominent German insurance company.

Also Read: Bitcoin: Here’s What Elon Musk’s Tesla Is Doing With Its BTC

Jio Financial Services’ Potential Partnership With Allianz

It should be noted that Bajaj Finserv Ltd., Allianz, has told its present partner that it is “actively considering an exit.” A disagreement about the course of the partnership is reportedly one of the primary reasons behind this departure.

But, disputes over the partnership’s future led to Allianz and Bajaj Finserv’s split. According to insiders, one of the main causes of the split was Bajaj’s unwillingness to let Allianz increase its ownership at a reduced cost.

Allianz plans to dissolve two joint ventures nationwide with this new insurance partnership. According to Bloomberg, Jio Financial and Allianz seek to open a life insurance and general insurance business in South Asian countries. The sources revealed that since the talks are still in their early phases, neither party may choose to proceed with the idea.

In addition, it seems like the partnership is still in its nascency. A spokesperson for Jio Financial Services said,

“If and when there are any material developments with respect to the company, we will continue to make necessary disclosures in accordance with our obligations, as we always have.”

Also Read: Tesla Q3 Earnings To Make TSLA A Magnificent 7 Stock?

Current Market Condition

At press time, Jio Financial Services stock was priced at 318 INR. This was achieved following a 1.26% rise over the past day. The highest that the stock surged to was 321.45 INR. But it dropped from 359 to 317 INR in less than a month. If the insurance partnership comes through, the stock could witness a massive uptick and reach 350 INR.

Also Read: Buy Jio Financial Shares: Revised Price Target 345: Analyst